Gastrointestinal stromal tumours of the stomach: Cytological and immunocytochemical diagnostic features of two cases diagnosed by endoscopic ultrasound‑guided fine needle aspiration

Todaro,P.; Crinò,S. F.; Pallio,S.; Fazzari,C.; Consolo,P.; Tuccari,G.

doi:10.3892/ol.2013.1296

Gastrointestinal stromal tumours of the stomach: Cytological and immunocytochemical diagnostic features of two cases diagnosed by endoscopic ultrasound‑guided fine needle aspiration

Authors:
- P. Todaro
- S. F. Crinò
- S. Pallio
- C. Fazzari
- P. Consolo
- G. Tuccari
View Affiliations

Affiliations: Department of Human Pathology, University of Messina, University-Hospital Health Network ‘Polyclinic G. Martino’, Messina I-98125, Italy, Digestive Endoscopy Unit, University of Messina, University-Hospital Health Network ‘Polyclinic G. Martino’, Messina I-98125, Italy
Published online on: April 10, 2013 https://doi.org/10.3892/ol.2013.1296
Pages: 1862-1866

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The present study reports the diagnostic utility of endoscopic ultrasound‑guided fine needle aspiration (EUS‑FNAC) in two patients affected by gastrointestinal stromal tumours (GISTs) of the stomach. Clinically, the patients demonstrated skin pallor, melena, gastric discomfort and pain that had lasted three days or weeks. The cytological findings are discussed; these were strongly supported by immunocytochemical procedures that were performed on cell blocks and further confirmed following post‑surgical histopathological examination. The crucial aim of GIST management is to determine a correct diagnosis in early‑phase disease in order to realize an adequate curative surgical resection before the tumour becomes unresectable or metastatic. Moreover, a correct pre-surgical differential diagnosis of GISTs from other mesenchymal neoplasms may be easily made by EUS-FNAC, supported by cytological and immunocytochemical features.

View Figures

View References

1	Emory TS, Sobin LH, Lukes L, Lee DH and O’Leary TJ: Prognosis of gastrointestinal smooth-muscle (stromal) tumours: dependence on anatomic site. Am J Surg Pathol. 23:82–87. 1999. View Article : Google Scholar : PubMed/NCBI
2	Miettinen M and Lasota J: Gastrointestinal stromal tumours - definition, clinical, histological, immunohistochemical, and molecular genetic features and differential diagnosis. Virchows Arch. 438:1–12. 2001. View Article : Google Scholar
3	Graadt van Roggen JF, van Velthuysen ML and Hogendoorn PC: The histopathological differential diagnosis of gastrointestinal stromal tumours. J Clin Pathol. 54:96–102. 2001.PubMed/NCBI
4	Miettinen M, El-Rifai W, Sobin L and Lasota J: Evaluation of malignancy and prognosis of gastrointestinal stromal tumours: a review. Hum Pathol. 33:478–483. 2002. View Article : Google Scholar : PubMed/NCBI
5	Wong DW, Lupton SC, Bhatt L, Gross L, Tanière P, Peake DR, Spooner D and Geh JI: Use of imatinib mesylate in gastrointestinal stromal tumours: Pan-Birmingham Cancer Network experience. Clin Oncol (R Coll Radiol). 20:517–522. 2008. View Article : Google Scholar : PubMed/NCBI
6	Versaci A, Macrì A, Ieni A, Terranova M, Leonello G, Saladino E, Speciale G and Famulari C: Gastrointestinal stromal tumour: our experience. Chir Ital. 61:161–169. 2009.(In Italian).
7	Maheshwari V, Alam K, Varshney M, Jain A, Asif Siddiqui F and Bhargava S: Fine-needle aspiration diagnosis of GIST: a diagnostic dilemma. Diagn Cytopathol. 40:834–838. 2012. View Article : Google Scholar : PubMed/NCBI
8	Chan JK: Mesenchymal tumours of the gastrointestinal tract: a paradise for acronyms (STUMP, GIST, GANT, and now GIPACT), implication of c-kit in genesis, and yet another of the many emerging roles of the interstitial cell of Cajal in the pathogenesis of gastrointestinal diseases? Adv Anat Pathol. 6:19–40. 1999.
9	Sircar K, Hewlett BR, Huizinga JD, Chorneyko K, Berezin I and Riddel RH: Interstitial cells of Cajal as precursors of gastrointestinal stromal tumours. Am J Surg Pathol. 23:377–389. 1999. View Article : Google Scholar : PubMed/NCBI
10	Lerma E, Oliva E, Tugués D and Prat J: Stromal tumours of the gastrointestinal tract: a clinicopathological and ploidy analysis of 33 cases. Virchows Arch. 424:19–24. 1994. View Article : Google Scholar : PubMed/NCBI
11	Mehta RM, Sudheer VO, John AK, Nandakumar RR, Dhar PS, Sudhindran S and Balakrishnan V: Spontaneous rupture of giant gastric stromal tumor into gastric lumen. World J Surg Oncol. 3:112005. View Article : Google Scholar : PubMed/NCBI
12	Dematteo RP, Heinrich MC, El-Rifai WM and Demetri G: Clinical management of gastrointestinal stromal tumours: before and after STI-571. Hum Pathol. 33:466–477. 2002. View Article : Google Scholar : PubMed/NCBI
13	Nilsson B, Bümming P, Meis-Kindblom JM, et al: Gastrointestinal stromal tumours: the incidence, prevalence, clinical course, and prognostication in the preimatinib mesylate era - a population-based study in western Sweden. Cancer. 103:821–829. 2005. View Article : Google Scholar
14	Reid R, O’Dywer P, MacDuff E, et al: Guidelines for the management of gastrointestinal stromal tumours (GIST) in Scotland. pp. 53–55. 2009, http://www.pathologyscotland.org/download/sgpg/guidelines/gist.pdf. Accessed November 13, 2012.
15	Demetri GD, von Mehren M, Blanke CD, et al: Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumours. N Engl J Med. 347:472–480. 2002. View Article : Google Scholar : PubMed/NCBI
16	Blay JY, Bonvalot S, Casali P, et al: GIST consensus meeting panelists: Consensus meeting for the management of gastrointestinal stromal tumours. Report of the GIST Consensus Conference of 20–21 March 2004, under the auspices of ESMO. Ann Oncol. 16:566–578. 2005.PubMed/NCBI
17	Blanke CD, Demetri GD, von Mehren M, et al: Long-term results from a randomized phase II trial of standard- versus higher-dose imatinib mesylate for patients with unresectable or metastatic gastrointestinal stromal tumours expressing KIT. J Clin Oncol. 26:620–625. 2008. View Article : Google Scholar
18	Nathan NA, Narayan E, Smith MM and Horn MJ: Cell block cytology. Improved preparation and its efficacy in diagnostic cytology. Am J Clin Pathol. 114:599–606. 2000. View Article : Google Scholar : PubMed/NCBI
19	Tuccari G, Giuffrè G, Scarfi R, Simone A, Todaro P and Barresi G: Immunolocalization of lactoferrin in surgically resected pigmented skin lesions. Eur J Histochem. 49:33–38. 2005. View Article : Google Scholar : PubMed/NCBI
20	Barresi V, Cerasoli S, Paioli G, Vitarelli E, Giuffrè G, Guiducci G, Tuccari G and Barresi G: Caveolin-1 in meningiomas: expression and clinico-pathological correlations. Acta Neuropathol. 112:617–626. 2006. View Article : Google Scholar : PubMed/NCBI
21	Jenssen C and Dietrich CF: Endoscopic ultrasound guided fine-needle aspiration biopsy and trucut biopsy in gastroenterology - An overview. Best Pract Res Clin Gastroenterol. 23:743–759. 2009. View Article : Google Scholar : PubMed/NCBI
22	Itoi T, Tsuchiya T, Itokawa F, Sofuni A, Kurihara T, Tsuji S and Ikeuchi N: Histological diagnosis by Eus-guided fine-needle aspiration biopsy in pancreatic solid masses without on-site cytopathologist: a single-center experience. Dig Endosc. 23(Suppl 1): 34–38. 2011. View Article : Google Scholar : PubMed/NCBI
23	Yoshinaga S, Suzuki H, Oda I and Saito Y: Role of endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) for diagnosis of solid pancreatic masses. Dig Endosc. 23(Suppl 1): 29–33. 2011. View Article : Google Scholar : PubMed/NCBI
24	Hoda KM, Rodriguez SA and Faigel DO: EUS-guided sampling of suspected GI stromal tumours. Gastrointest Endosc. 69:1218–1223. 2009. View Article : Google Scholar : PubMed/NCBI
25	Panizo-Santes A, Sola I, Vega F, de Alava E, Lozano MD, Idoate MA and Pardon-Mindán J: Predicting metastatic risk of gastrointestinal stromal tumours: role of cell proliferation and cell cycle regulatory proteins. Int J Surg Pathol. 8:133–144. 2000. View Article : Google Scholar : PubMed/NCBI
26	Fletcher CD, Berman JJ, Corless C, et al: Diagnosis of gastrointestinal stromal tumours: A consensus approach. Hum Pathol. 33:459–465. 2002. View Article : Google Scholar : PubMed/NCBI
27	Koon N, Schneider-Stock R, Sarlomo-Rikala M, Lasota J, Smolkin M, Petroni G, Zaika A, Boltze C, Meyer F, Andersson L, Knuutila S, Miettinen M and El-Rifai W: Molecular targets for tumour progression in gastrointestinal stromal tumours. Gut. 53:235–240. 2004. View Article : Google Scholar : PubMed/NCBI
28	Kim KM, Kang DW, Moon WS, et al Gastrointestinal stromal tumor committee; The Korean Gastrointestinal Pathology Study Group: Gastrointestinal stromal tumours in Koreans: it’s incidence and the clinical, pathologic and immunohistochemical findings. J Korean Med Sci. 20:977–984. 2005.
29	O’Sullivan B, Deshmukh N, Reynolds G, et al: Retrospective analysis of GIST in one regional UK reference centre. Gut. 56(S1): A72007.
30	Ueyama T, Guo KJ, Hashimoto H, Daimaru Y and Enjoji M: A clinicopathologic and immunohistochemical study of gastrointestinal stromal tumours. Cancer. 69:947–955. 1992. View Article : Google Scholar : PubMed/NCBI
31	Miettinen M and Lasota J: Gastrointestinal stromal tumours: review on morphology, molecular pathology, prognosis, and differential diagnosis. Arch Pathol Lab Med. 130:1466–1478. 2006.PubMed/NCBI